TGFB1 and cancer: Current findings may be explained by a Treg subset of CD4+ T cells having cycled from cancer tissue into blood; alternatively, elevated levels of circulating cytokines such as IL-6, IL-10, and TGFβ may explain the tumor-suppressive profile in these blood samples [50,55].